Brain cancer doesn’t use the traditional staging system (stage 1 through 4) that most other cancers use. Instead, brain tumors are classified by grades, ranging from grade 1 (slowest growing, least aggressive) to grade 4 (fastest growing, most aggressive). This distinction matters because the grade of a brain tumor drives nearly every decision about treatment and gives the clearest picture of what to expect going forward.
Why Brain Cancer Uses Grades, Not Stages
For most cancers, doctors use the TNM system, which tracks tumor size, lymph node involvement, and whether the cancer has spread to distant organs. Brain tumors are different. The National Cancer Institute specifically lists brain and spinal cord tumors as cancers that follow a separate system. The reason is straightforward: primary brain tumors rarely spread outside the central nervous system. What matters most isn’t whether the tumor has traveled to another organ but how the tumor cells look and behave under a microscope and, increasingly, what genetic mutations they carry.
The World Health Organization (WHO) grading system, first published in 1979, assigns brain tumors a grade from 1 to 4. The most recent update in 2021 (called WHO CNS5) made a major shift by incorporating specific genetic markers alongside traditional microscopic analysis. For example, a tumor’s IDH mutation status now directly influences whether it’s classified as grade 2, 3, or 4. This means two tumors that look identical under a microscope might receive different grades based on their molecular profile.
Grade 1: Slow-Growing and Often Curable
Grade 1 brain tumors are the least aggressive. They grow slowly, have well-defined borders, and the cells look relatively normal under a microscope. The most common example is pilocytic astrocytoma, which typically appears in children and young adults. These tumors arise from the brain’s supporting cells and can often be cured with surgery alone if the entire tumor can be removed.
Other grade 1 tumors include most meningiomas (about 85% of which are noncancerous and slow-growing), pituitary adenomas, and acoustic neuromas. Many grade 1 tumors are discovered incidentally during imaging for an unrelated issue and may be monitored without immediate treatment if they aren’t causing symptoms.
Grade 2: Low-Grade but Still a Concern
Grade 2 tumors grow slowly but have a more infiltrative quality than grade 1 tumors. Their cells look slightly more abnormal, and the borders between the tumor and healthy brain tissue are less distinct. Diffuse astrocytoma is the classic grade 2 tumor. Unlike grade 1 tumors, grade 2 tumors have a meaningful risk of progressing to a higher grade over time. This is a key point that catches many people off guard: a tumor that starts as grade 2 can transform into a grade 3 or 4 tumor years later.
Treatment for grade 2 tumors varies. Surgery to remove as much of the tumor as possible is typical when the location allows it. Depending on the tumor’s molecular profile and how much was removed, some patients receive radiation or chemotherapy afterward, while others are monitored with regular MRI scans.
Grade 3: Actively Malignant
Grade 3 tumors are cancerous and grow more aggressively. Under a microscope, they show a feature called anaplasia, meaning the cells are dividing rapidly and look increasingly abnormal. These tumors require more aggressive treatment, typically a combination of surgery, radiation, and chemotherapy.
In the older classification system, a grade 3 brain tumor originating from star-shaped brain cells was called “anaplastic astrocytoma” and treated as its own diagnosis. Under the 2021 WHO system, that label is no longer used as a standalone tumor type. Instead, doctors classify the tumor by its genetic mutations first, then assign a grade of 2, 3, or 4 based on both the microscopic appearance and those molecular findings. This change reflects the reality that a tumor’s genetic makeup is a better predictor of how it will behave than its appearance alone.
Grade 4: The Most Aggressive
Grade 4 is the highest and most serious grade. These tumors grow rapidly, form new blood vessels to feed their growth (a feature called microvascular proliferation), and contain areas of dead tissue called necrosis. Both of these microscopic features are hallmarks that pathologists look for when assigning a grade 4 classification.
Glioblastoma is the most well-known grade 4 brain tumor and one of the most aggressive cancers in the body. The standard treatment is surgery to remove as much of the tumor as possible, sometimes with medicated wafers implanted directly into the brain at the surgical site. This is followed by about six and a half weeks of daily radiation combined with oral chemotherapy, then an additional six months of chemotherapy taken five days per month. Even with this intensive approach, glioblastomas almost always recur.
The overall five-year relative survival rate for brain and nervous system cancers is 32.9%, though this number blends together every type and grade. Grade 1 tumors have dramatically better outcomes than grade 4. Survival for localized brain tumors sits at about 35.3%, while tumors that have spread regionally drop to 20.1%.
How Doctors Determine the Grade
Grading a brain tumor requires a tissue sample. MRI scans can suggest whether a tumor is likely low-grade or high-grade based on its appearance, growth pattern, and how it absorbs contrast dye, but the definitive answer comes from examining tumor cells under a microscope and running genetic tests.
Most brain biopsies today are stereotactic needle biopsies. This technique uses MRI or CT imaging combined with computer guidance to map the brain in 3D and direct a needle to the exact tumor location through a small opening in the skull. Frameless systems that use markers placed on the scalp are the most common approach. Stereotactic biopsy is preferred when the tumor sits deep in the brain or near critical structures where open surgery would carry higher risk. It allows doctors to make a diagnosis without removing a large amount of tissue.
Once the sample is obtained, a pathologist examines the cells for signs of abnormality and runs molecular tests for genetic markers like IDH mutations. These results together determine the final grade and guide treatment planning.
How Grade Affects Treatment Decisions
The treatment gap between low-grade and high-grade brain tumors is significant. For a grade 1 meningioma or pilocytic astrocytoma, complete surgical removal may be the only treatment needed, and many patients return to normal life. Some grade 1 tumors that aren’t causing symptoms may simply be watched over time with periodic imaging.
Grade 2 tumors occupy a middle ground. Surgery is the first-line approach, but the decision about additional treatment depends heavily on molecular testing, how much tumor remains after surgery, and the patient’s age and overall health. Some patients begin radiation and chemotherapy right away, while others defer additional treatment until there are signs of progression.
Grade 3 and 4 tumors almost always require the full combination of surgery, radiation, and chemotherapy. For glioblastoma specifically, temozolomide is the standard chemotherapy drug. It’s taken as a pill and works by slowing tumor growth. Radiation may also be used as the primary treatment for patients who aren’t well enough for surgery. Despite aggressive treatment, high-grade tumors have a strong tendency to return, often within months for grade 4 tumors. The focus of treatment shifts over time toward maintaining quality of life and managing symptoms alongside efforts to control tumor growth.